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Objectives. To assess the outcome of AAA repair in patients with established renal failure (RF), including patients on
dialysis.
Design. Retrospective case–control study in a teaching hospital.
Methods. All patients with established RF undergoing AAA repair were identified during the last eight years. Data was
collected from patient notes on operative difficulty, hospital mortality, survival time and future dialysis requirements. For
comparison, 28 consecutive patients undergoing AAA repair without RF were studied prospectively.
Results. Thirteen RF patients were identified. Three were receiving Continuous Ambulatory Peritoneal Dialysis (CAPD),
three were receiving Haemodialysis (HD) and seven had established RF, but were not receiving dialysis. Compared with the
control patients, RF patients had a longer total hospital stay (p ¼ 0.03, 95% CI for median stay224.3 to24.0 days), more
postoperative complications (p , 0.01, 95% CI 26.4–73.7%) and had an increased in-hospital mortality (p ¼ 0.02, 95% CI
4.6–54.3%). Four of the six survivors who were non-dialysis-dependent required long-term dialysis postoperatively.
Conclusions. AAA repair in RF patients is associated with increased postoperative morbidity and mortality. Previously
non-dialysis-dependent patients have a high risk of subsequent long-term dialysis.
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Introduction
There are an estimated 500–1000 patients per million
in the United Kingdom with chronic renal impair-
ment.1 The incidence of patients starting renal replace-
ment therapy (RRT) is 96 per million per year, and the
prevalence of patients receiving RRT is 526 per million
in the UK.2 The figures compare to 296/1,000,000 and
1131/1,000,000, respectively, in the United States.
Due to a high incidence of concurrent cardiovas-
cular morbidity, these patients are at risk of aneur-
ysmal disease. Abdominal aortic aneurysm (AAA)
repair is a major operation with significant associated
mortality and morbidity even amongst the fittest
subjects, and the presence of pre-existing renal failure
has been identified as a risk factor for poor post-
operative outcome,3 – 5 and reduced late survival.6
We assessed the outcome of AAA repair in patients
with established renal failure (RF), including those
requiring regular dialysis, in a single UK centre, with
both regional vascular and nephrology units, and a
referral population in excess of one million. The main
outcome measures were hospital mortality, the inci-
dence of postoperative complications and the duration
of postoperative hospital stay.
Materials and Methods
All patients known to the renal services unit with a
diagnosis of renal impairment or end-stage renal
failure that subsequently underwent AAA repair at
the University Hospitals of Leicester (UHL) NHS Trust
were identified between July 1995 and July 2003 using
the hospital database and coding system. The data
search combined the keyword ‘aortic aneurysm’ with
the keywords ‘renal failure’ and ‘dialysis’. To reduce
the chance of cases being overlooked, a list of all
patients known to the renal services unit was compiled
and compared with a list of all patients undergoing
AAA repair, obtained from our vascular database. The
notes of any duplicate names were then examined for
relevance to the study.
A retrospective search of all patient notes was
conducted. Outcome measures were recorded firstly
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on the operation itself (including operative length,
operative blood loss, intraoperative fluid replacement
and documented intraoperative complications), sec-
ondly on patient outcome in terms of mortality and
survival time, and thirdly on patient outcome in terms
of dialysis requirement.
An intraoperative complication was defined by the
following: bleeding that was difficult to control,
arterial embolism, bowel ischaemia, cardiac event
and friable or heavily calcified vessels. Postoperative
complications were defined using the POSSUM
methodology7 (Table 1).
For comparison, 29 consecutive patients
(unmatched) with normal renal function, undergoing
open, transperitoneal repair of infrarenal AAA at UHL
were studied prospectively over a one-year period.
The same information was recorded as for the study
group.
For discussion, the renal failure patients are referred
to as the ‘cases’ and the comparison group as the
‘controls’. End-stage renal failure was defined as an
irreversible disease process with a serum creatinine
.5.6 mg/dl (.500 mmol/l). Renal impairment was
defined as a serum creatinine .2 mg/dl
(.176 mmol/l).
Statistical analysis uses SPSS version 11w. Normally
distributed data is expressed as the mean and
(standard deviation). Non-normally distributed data
is expressed as the median and (interquartile range).
Normality of data was tested using SPSS. Data was
assumed to be normally distributed if the skewness
value given was less than twice its standard error.
Statistical tests are restricted to our primary hypoth-
eses; namely to investigate whether there is a
difference between the two groups in the number of
postoperative complications, the length of hospital
stay postoperatively and hospital mortality. Differ-
ences between other variables are described with 95%
confidence intervals.
Results
A total of 13 patients with renal impairment or end-
stage renal failure undergoing AAA repair were
identified between July 1995 and July 2003. These
comprised 11 men and 2 women. The mean age was
69.9 years (range 62–76). The demographic data for
these patients and the control group are given in Table
2. These data demonstrate that despite the groups
being unmatched, they are similar in terms of age and
sex distribution, as well as for incidence of co-
morbidity.
Patients with renal failure varied in their dialysis
requirements and in the type of dialysis used. Three
patients were receiving regular Continuous Ambulat-
ory Peritoneal Dialysis (CAPD), three patients were
receiving regular haemo-dialysis (HD) and seven
patients had established renal failure or renal impair-
ment under the care of the nephrologists, but were not
receiving any form of regular dialysis. The mean
preoperative creatinine for these six patients was 308.6
(178.0) mmol/l (3.4 (2.0) mg/dl).
Concentrating on operative factors (Table 3),
patients with renal failure had higher mean POSSUM
Operative Severity Scores (mean difference 2.8, 95% CI
0.35–5.25), required larger blood transfusions in
theatre (95% CI for difference in medians 2.0–4.8
units) and experienced 41% (95% CI 9.2–63.9%) more
operative complications in comparison to the control
patients. The operative procedures were comparable
between the two groups, with all patients undergoing
open, transperitoneal repairs of infrarenal aneurysms.
The POSSUM Operative Severity Scores were higher
in the renal failure group largely as a result of the
increased operative blood loss.
Postoperatively, patients with renal failure
remained longer on the Critical Care Unit (95% CI
for median difference 0.0–8.4) and had a longer total
hospital stay than the control patients (p , 0:01
Table 1. Summary of complications (morbidity), as described by
Copeland et al.7
Type of complication
Haemorrhage
Wound
Deep
Other
Infection
Chest
Wound
Urinary tract
Respiratory
Septicaemia
Pyrexia of unknown origin
Other
Wound dehiscence
Superficial
Deep
Anastomotic leak
Thrombosis
Deep venous thrombosis
Pulmonary embolism
Other
Cerebrovascular accident
Myocardial infarction
Cardiac failure
Impaired renal function
Hypotension
Respiratory failure
Any other complication
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(Mann–Whitney U Test) 95% CI for median difference
4.0–24.3). Patients with renal failure also had a 57.8%
(95% CI 26.4–73.7) higher incidence of postoperative
complications (p , 0:01 Fisher’s Exact Test) and
experienced a 27.3% (95% CI 4.6–54.3) higher in-
hospital mortality rate (p ¼ 0:02 Fisher’s Exact Test)
compared with control patients (Table 4).
With regards to the three patients receiving CAPD,
one died in the early postoperative period, one was
found to have an inoperable aorta at laparotomy and
one patient survived (requiring long-term HD until
subsequent transplantation). Of the three patients on
HD, one survived to leave hospital, and two died in
the perioperative period. Of the seven patients
managed conservatively (i.e. not on dialysis), six
survived to leave hospital. Four of these, however,
required long-term dialysis (Fig. 1).
Discussion
The results from this study suggest that aortic surgery
in patients with renal failure is associated with a high
postoperative morbidity and mortality, and can be
technically more difficult. In addition to this, pre-
viously non-dialysis-dependent patients have a high
risk of requiring subsequent long-term dialysis. This
has quality of life and financial implications for both
the patient and for health service provision,
respectively.
Previous research looking specifically at the out-
come of AAA repair in patients with renal failure is
sparse. A review of the literature reveals three studies;
two undertaken in Japan in the 1990s8,9 and one from
the US in the late 1970s/early 1980s.10 These papers
are interesting, and differ from our study in a number
of ways. Sugawara et al.9 demonstrated a significantly
higher rate of postoperative complications in patients
with chronic renal dysfunction, but with no significant
difference in hospital mortality. This low mortality rate
may reflect the use of a lower level of serum creatinine
for the definition of renal dysfunction (serum creati-
nine $1.5 mg/dl or ^ 132 mmol/l), thereby includ-
ing a greater proportion of patients with less severe
renal dysfunction, that may do better postoperatively,
thereby skewing the results. Komori et al.8 demon-
strated no difference in either operative mortality or
complications in patients with renal failure (defined by
serum creatinine of $2.0 mg/dl or 176 mmol/l),
compared to those with normal renal function. The
renal failure group also included three patients on
haemodialysis, although their mortality rate is not
stated. Also of interest, none of the renal failure group
required haemodialysis postoperatively during hospi-
talisation, however, the number of patients that
subsequently required dialysis is not stated.
These patients did, however, have a significantly
Table 2. Patient demographics. Mean values are followed by the standard deviation (in brackets), median values are followed by the
interquartile range (in brackets)
Cases ðn ¼ 13Þ Controls ðn ¼ 29Þ Difference* (95% CI)
Mean age (years) 69.9 (5.53) 69.8 (6.75) 0.1 (24.2 to 4.4) years
Male sex 11 (85%) 25 (86%) 21% (229.7 to 18.5)
Median aneurysm size (cm) 6.2 (5.95–6.6) 6.0 (5.6–6.25) (20.6 to 0.0)
Positive smoking history 12 (92%) 25 (86%) 6% (220.8 to 24)
Incidence of diabetes 2 (15%) 3 (10%) 5% (214.4 to 32.7)
Incidence of ischaemic heart disease 6 (46%) 11 (38%) 8% (221.0 to 37.3)
Incidence of peripheral vascular disease 6 (46%) 6 (21%) 25% (23.5 to 52.4)
Incidence of cerebrovascular disease 3 (23%) 3 (10%) 13% (29.2 to 40.7)
Incidence of raised cholesterol 4 (31%) 4 (14%) 17% (27.7 to 45.1)
Median POSSUM acute physiology score 26 (20.5–33.5) 17 (15.25–19.75) (215.0 to 23.6)
*Point estimate of median differences not calculable.
Table 3. Operative details for both groups
Cases ðn ¼ 13Þ Controls ðn ¼ 29Þ Difference* (95% CI)
Number of cases with iliac involvement 7 (54%) 6 (21%) 33% (2.8–58.5)
Number of patients with straight graft 4 (31%) 23 (79%) 248% (269.6 to 216.4)
Median operative length in minutes (IQR) 180 (150–255) 153 (125–192) (2113.0 to 10.0)
Median operative blood loss in ml (IQR) 1600 (1000–2000) 1000 (600–1850) (21100 to 500)
Number of operative complications 9 (69%) 8 (28%) 41% (9.2 to 63.9)
Median intra-operative fluid replacement in litres (IQR) 5.0 (3.5–6.375) 5.75 (4.5–6.5) (21.1 to 2.5)
Median intra-operative blood transfusion in units (IQR) 4.46 (3.0–6.5) 2.0 (0.0–3.75) (2.0 to 4.8)
Mean POSSUM operative severity score (SD) 20.69 (4.13) 17.89 (3.40) 2.8 (0.35 to 5.25)
*Point estimate of median differences not calculable.
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reduced 5-year survival rate (43.5 versus 78.1). One
final point of interest from this paper is that a third
group of renal failure patients managed non-opera-
tively is also included. The reasons for a non-operative
approach are not, however, discussed. Surprisingly,
these patients had a 5-year survival rate of 20%, with
39% of patients dying from rupture. The results from
an earlier paper by Cohen et al.10 are more in keeping
with our study, with 25% mortality in patients on
haemodialysis, and 67% of patients with a preopera-
tive creatinine of .4 mg/dl requiring dialysis. In
addition to these papers that specifically address the
suitability of AAA repair in patients with renal failure,
other large series exist in the literature that investigate
the effect of renal failure in subsets of patients. Hertzer
et al.11 in a series of 1135 patients undergoing AAA
repair demonstrated a significantly reduced 10-year
life expectancy in patients with a serum creatinine of
$2 mg/dl compared to patients with normal renal
function. A further large series ðn ¼ 1000Þ by Lloyd
et al.,12 did not, however, demonstrate any increased
mortality in patients with renal impairment compared
to patients with normal renal function.
Despite the interesting findings from this study,
possible shortcomings must include the retrospective
design, and the relatively small numbers of patients,
which are obvious limitations with any research, and
which may introduce bias. It is possible that some
patients may have been overlooked or not considered
for surgery, and that some of the variables measured in
the 13 study patients may have been under-rep-
resented. A second criticism is of patient selection.
By only including patients with renal dysfunction who
are already know to nephrology services, we may have
inadvertently selected a group of patients with more
advanced renal disease that may be expected to have a
less favourable outcome. In contrast, the two Japanese
studies included all patients with any renal dysfunc-
tion. If we had done this, our results may have been
different, but a study such as this could not be
conducted in our centre, as the preoperative creatinine
values are not recorded electronically on every patient
undergoing AAA repair. A final criticism is that of
potential over-interpretation of findings due to per-
forming multiple statistical tests. We have kept this to
a minimum by stating our three primary hypotheses a
priori and not reporting tests of significance for the
other variables. Despite small numbers, and using p-
value adjustment (Bonferroni method), the differences
for all three outcome measures were significant.
Table 4. Hospital outcome. All results are expressed as the median value, with the interquartile range in brackets unless otherwise stated.
P-values are included for the primary outcomes
Cases ðn ¼ 13Þ Controls ðn ¼ 29Þ Difference* (95% CI) P-value
Critical Care Unit stay in days 5.0 (1.5–12.5) 2.0 (1.0–3.0) (28.4 to 0.0) NA
Ward stay in days 13.0 (7.5–38.5) 7.0 (6.0–10.0) (211.0 to 22.7) NA
Hospital stay In days 17.5 (15.0–55.0) 10.0 (8.0–13.0) (224.3 to 24.0) p , 0:01
Number of post-op complication (%) 12 (92%) 10 (34%) 58% (26.4 to 73.7%) p , 0:01
Number of hospital deaths (%) 4 (31%) 1 (3.4%) 27.6% (4.6 to 54.3) p ¼ 0:02
*Point estimate of median differences not calculable.
Fig. 1. Diagrammatic summary of the outcome of AAA repair in patients with renal failure.
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Despite the criticisms above, our results have
important implications for patients with renal disease
referred for aneurysm repair. Firstly, patient consent is
of paramount importance. The high mortality amongst
dialysis patients must be adequately stressed, as
should the high potential for the subsequent deterio-
ration of renal function requiring long-term dialysis.
Secondly, patient selection must be carefully con-
sidered, with close discussion between the family, the
surgeon, the renal team and the anaesthetist. A
decision of not repairing the aneurysm must also be
considered. Thirdly, where suitable these patients
should be considered for endovascular repair
(EVAR), as there is some evidence that high-risk
patients with renal impairment may have an improved
outcome with EVAR compared to open surgery.13 With
anatomy permitting, EVAR in dialysis patients
especially, may be technically more straightforward
as suprarenal stent placement and the use of intrave-
nous contrast is of little consequence. These results do
not preclude the undertaking of AAA repair in
patients with renal failure, but rather add a cautionary
note to the results of previous studies.8,9
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